Native American tribe seeks information on PTAB judges

A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board (PTAB) judges overseeing inter partes reviews (IPRs) involving the tribe.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Allergan tries to escape Restasis IPRs

10 January 2018 Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).

Americas

PTAB dismisses Native American tribe information request

8 January 2018 The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.

Americas

Native American tribe hits back at Mylan in PTAB filing

24 October 2017 The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Native American tribe seeks information on PTAB judges

More on this story

Editor's picks

Editor's picks

More features